23 July 2022>: Clinical Research
Time of Resumption of Antiplatelet Drugs After Upper Gastrointestinal Hemorrhage
Huan Ma ABCDEF* , Xiao Fan B , Li Jiao BC , Xia Meng BDE , Liwei Zhao BDF , Junmin Wang ACEFDOI: 10.12659/MSM.936953
Med Sci Monit 2022; 28:e936953
Table 1 Basic information of patients in each group.
Basic information | Aspirin group (n=90)3-day (45) 7-day (45) | Aspirin+clopidogrel group(n=58)0+3-day (20) 3+7-day (19) 0+7-day (19) | |||
---|---|---|---|---|---|
Male, n (%) | 24 (53.3) | 25 (55.6) | 11 (55.0) | 12 (63.2) | 10 (52.3) |
Mean age (SD) | 68 (7) | 69 (7) | 74 (5) | 76 (4) | 75 (6) |
Alcohol abuse, n (%) | 2 (4.4) | 3 (6.7) | 2 (10.0) | 1 (5.3) | 1 (5.3) |
Smoke, n (%) | 8 (17.8) | 10 (22.2) | 4 (20.0) | 4 (21.0) | 3 (15.8) |
Reasons for using antiplatelet drugs, n (%) | |||||
Cardiovascular disease | 25 (55.6) | 26 (57.8) | 18 (90.0) | 16 (84.2) | 16 (84.2) |
Cerebrovascular diseases | 15 (33.3) | 15 (33.3) | 1 (5.0) | 3 (15.8) | 2 (10.5) |
Cardiovascular and cerebrovascular diseases | 5 (11.1) | 4 (8.9) | 1 (5.0) | 0 (0) | 1 (5.3) |
Hemoglobin (SD), g/l | 89 (8.3) | 91 (7.9) | 86 (10.1) | 82 (9.2) | 84 (11.0) |
Peptic ulcer, n (%) | |||||
Gastric ulcer | 25 (55.6) | 24 (53.3) | 13 (65.0) | 10 (52.3) | 10 (52.3) |
Duodenal ulcer | 20 (44.4) | 20 (44.4) | 7 (35.0) | 9 (47.4) | 8 (42.1) |
Gastroduodenal ulcer | 0 (0) | 1 (2.2) | 0 (0) | 0 (0) | 1 (5.3) |
Forrest classification, n (%) | |||||
Ia+Ib | 10 (22.2) | 12 (26.7) | 6 (30.0) | 7 (36.8) | 6 (31.6) |
IIa | 14 (31.1) | 15 (33.3) | 8 (40.0) | 6 (31.6) | 8 (42.1) |
IIb | 9 (20.0) | 9 (20.0) | 3 (15.0) | 4 (21.1) | 3 (15.8) |
IIc+III | 12 (26.7) | 10 (22.2) | 3 (15.0) | 2 (10.5) | 2 (10.5) |